Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Reg Anesth Pain Med ; 47(7): 430-433, 2022 07.
Article in English | MEDLINE | ID: mdl-35361696

ABSTRACT

BACKGROUND: There is increasing evidence for the use of multilevel epidural catheter-guided blood patches to treat spontaneous cerebrospinal fluid leaks in adults. Yet, there are scarce data for their use in children. Furthermore, higher level epidural blood patches are uncommon in both adult and pediatric populations. CASE PRESENTATION: An adolescent boy with multilevel cerebrospinal fluid leaks associated with status migrainosus failed conservative pain management treatment. As he remained severely symptomatic, epidural blood patches were required to mitigate his symptoms. Given his multilevel leaks, a catheter-guided blood patch approach was used to treat multiple cervicothoracic and thoracolumbar leaks. After three separate uneventful blood patch procedures, the patient was free of symptoms. Other than some rebound intracranial hypertension, the patient maintained full neurological capacity without further complications. Following the resolution of treatment, he has not sought help for pain since his last blood patch over a year ago. CONCLUSIONS: Multilevel catheter-guided blood patches have the potential to be administered to higher level spinal regions to the pediatric population suffering from multiple spontaneous cerebrospinal fluid leaks.


Subject(s)
Blood Patch, Epidural , Catheters , Cerebrospinal Fluid Leak , Adolescent , Blood Patch, Epidural/methods , Cerebrospinal Fluid Leak/therapy , Humans , Male
2.
J Minim Invasive Gynecol ; 21(5): 863-9, 2014.
Article in English | MEDLINE | ID: mdl-24727030

ABSTRACT

STUDY OBJECTIVE: To evaluate the effects of peritoneal cold nebulization of ropivacaine on pain control after gynecologic laparoscopy. DESIGN: Evidence obtained from a properly designed, randomized, double-blind, placebo-controlled trial (Canadian Task Force classification I). SETTING: Tertiary care center. PATIENTS: One hundred thirty-five women with American Society of Anesthesiologists disease classified as ASA I-III who were scheduled to undergo operative laparoscopy. INTERVENTION: Patients were randomized to receive either nebulization of 30 mg ropivacaine before surgery (preoperative group), nebulization of 30 mg ropivacaine after surgery (postoperative group), instillation of 100 mg ropivacaine before surgery (instillation group), or instillation of saline solution (control group). Nebulization was performed using the Aeroneb Pro device. MEASUREMENT AND MAIN RESULTS: Pain scores, morphine consumption, and ambulation time were collected in the post-anesthesia care unit and at 4, 6, and 24 hours postoperatively. One hundred eighteen patients completed the study. Patients in the preoperative group reported lower pain Numeric Ranking Scale values compared with those in the control group (net difference 2 points; 95% confidence interval [CI], 0.3-3.1 at 4 hours, 1-3 at 6 hours, and 0.7-3 at 24 hours; p = .01) Patients in the preoperative group consumed significantly less morphine than did those in the control group (net difference 7 mg; 95% CI, 0.7-13; p = .02). More patients who received nebulization walked without assistance within 12 hours after awakening than did those in the instillation and control groups (net difference 15%; 95% CI, 6%-24%; p = .001). CONCLUSIONS: Cold nebulization of ropivacaine before surgery reduced postoperative pain and morphine consumption and was associated with earlier walking without assistance.


Subject(s)
Amides/administration & dosage , Analgesics, Opioid/administration & dosage , Anesthetics, Local/administration & dosage , Gynecologic Surgical Procedures , Laparoscopy , Morphine/administration & dosage , Pain, Postoperative/prevention & control , Postoperative Nausea and Vomiting/prevention & control , Adult , Double-Blind Method , Early Ambulation , Female , Gynecologic Surgical Procedures/adverse effects , Humans , Infusions, Parenteral , Laparoscopy/adverse effects , Nebulizers and Vaporizers , Pain Measurement , Pain, Postoperative/drug therapy , Ropivacaine , Treatment Outcome
3.
Curr Drug Targets ; 13(7): 936-43, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22512393

ABSTRACT

Almost all children in the pediatric intensive care (PICU) need analgesia and/or sedation. Analgesics drugs are used to control pain from surgical incisions, drainages, vascular access or endotracheal suctioning. Sedatives are used to facilitate the delivery of nursing care, to facilitate mechanical ventilation, prevent self-extubation and to minimize patient discomfort. A therapeutic plan for analgesia and sedation should be established for each patient and regularly reviewed. The most often used sedation agents in PICU patients are Morphine or Fentanyl alone or in combination with Midazolam. Several other drugs should be helpful to manage PICU patients therefore techniques like regional anesthesia and patient controlled analgesia to decrease the use of intravenous analgesia and sedation and to reduce the incidence of withdrawal syndrome. The therapeutic plan for analgesia and sedation should be established for each patient and regularly reviewed. Doses of sedative agents should be titrated to produce the desired level of sedation. The level of sedation should be regularly assessed and documented using few validated sedation assessment tool. However, behavioral evaluation tools based on patient responsiveness, cannot be used during the administration of neuromuscular blocking agents. Under this conditions it could be difficult to interpret the degree of sedation. EEG derived Monitoring devices may represents an useful tools of assessing the level of sedation, but there is insufficient evidence to support the routine use of the BIS monitor in PICU.


Subject(s)
Analgesia , Hypnotics and Sedatives/therapeutic use , Intensive Care Units, Pediatric , Analgesics/therapeutic use , Child , Electroencephalography , Humans , Pain Measurement , Substance Withdrawal Syndrome
4.
Paediatr Anaesth ; 17(5): 445-51, 2007 May.
Article in English | MEDLINE | ID: mdl-17474951

ABSTRACT

BACKGROUND: Monitoring of anesthesia depth is difficult clinically, particularly in children. The aim of this study was to assess the correlation existing between CSI (Cerebral State Index), or AAI (A-line ARX) and a clinical sedation scale such as UMSS (University of Michigan Sedation Scale), during deep sedation with propofol in children undergoing diagnostic procedures. METHODS: Twenty ASA I and II children, scheduled to undergo deep sedation for magnetic resonance imaging (MRI) or Esophagogastroduodenoscopy (EGDS), were enrolled. The patients were randomly assigned to receive depth of anesthesia monitoring with CSI or AAI. The anesthetist administered repeated doses of propofol every 10 s to a UMSS score of 3-4. An attending anesthetist, not involved in drug administration, recorded time and doses of sedation medications, vital signs, UMSS score and CSI or AAI score. All the evaluations were recorded at awake state (baseline), every 10 s until an UMSS score of 3-4 and every 3 min until the children were awake. RESULTS: We enrolled 13 males and seven females ranging in age from 8 months to 7 years. After induction of anesthesia CSI and AAI scores decreased and from the end of the procedure to emergence the two scores increased. The CSI data showed a strong correlation with the UMSS scores (r = -0.861; P < 0.0001); we found a similar correlation between the AAI data and the UMSS scores (r = -0.823; P < 0.0001). CONCLUSIONS: Our study suggests that CSI and AAI may be two, real-time and objective tools to assess induction and emergence during propofol sedation in children undergoing EGDS and MRI.


Subject(s)
Brain/drug effects , Conscious Sedation/methods , Electroencephalography/methods , Endoscopy, Digestive System/methods , Evoked Potentials, Auditory/drug effects , Magnetic Resonance Imaging/methods , Anesthesia Recovery Period , Anesthetics, Intravenous/administration & dosage , Child , Child, Preschool , Drug Administration Schedule , Electrocardiography/methods , Female , Heart Rate/drug effects , Humans , Infant , Male , Monitoring, Physiologic/methods , Propofol/administration & dosage , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...